K Gemzell-Danielsson

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi request reprint Effects of mifepristone on endometrial receptivity
    Kristina Gemzell Danielsson
    Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Hospital Institute, Stockholm S 171 76, Sweden
    Steroids 68:1069-75. 2003
  2. ncbi request reprint Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception
    K Gemzell-Danielsson
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital Institute, S 171 76 Stockholm, Sweden
    Hum Reprod Update 10:341-8. 2004
  3. ncbi request reprint Misoprostol to treat missed abortion in the first trimester
    K Gemzell-Danielsson
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Int J Gynaecol Obstet 99:S182-5. 2007
  4. ncbi request reprint Effects of levonorgestrel on ovarian function when used for emergency contraception
    K Gemzell-Danielsson
    Department of Woman and Child Health, Karolinska University Hospital Karolinska Institutet, Stockholm, Sweden
    Minerva Ginecol 58:205-7. 2006
  5. ncbi request reprint Studies on uterine contractility following mifepristone and various routes of misoprostol
    Kristina Gemzell-Danielsson
    Department of Obstetrics and Gynecology, Karolinska University Hospital, Karolinska Institute, SE 171 76 Stockholm, Sweden
    Contraception 74:31-5. 2006
  6. ncbi request reprint Pharmacokinetics of a novel oral slow-release form of misoprostol
    C Fiala
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, S 171 76 Stockholm, Sweden
    Hum Reprod 20:3414-8. 2005
  7. doi request reprint Effects of oral and vaginal administration of levonorgestrel emergency contraception on markers of endometrial receptivity
    C X Meng
    Division of Obstetrics and Gynaecology, Department of Women s and Children s Health, Karolinska University Hospital Karolinska Institutet, SE 17176 Stockholm, Sweden
    Hum Reprod 25:874-83. 2010
  8. doi request reprint Replication of endometriosis-associated single-nucleotide polymorphisms from genome-wide association studies in a Caucasian population
    J Sundqvist
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Hospital, SE 17176 Stockholm, Sweden
    Hum Reprod 28:835-9. 2013
  9. doi request reprint Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days
    H Kopp Kallner
    Division of Obstetrics and Gynaecology, Department of Women s and Children s Health, Karolinska Institutet Karolinska University Hospital, 171 76 Stockholm, Sweden
    Hum Reprod 25:1153-7. 2010
  10. ncbi request reprint The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation
    C Fiala
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Clinical Epidemiology Unit, Karolinska Institute, 171 76 Stockholm, Sweden
    Hum Reprod 20:3072-7. 2005

Collaborators

Detail Information

Publications59

  1. ncbi request reprint Effects of mifepristone on endometrial receptivity
    Kristina Gemzell Danielsson
    Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Hospital Institute, Stockholm S 171 76, Sweden
    Steroids 68:1069-75. 2003
    ..Our findings provide insight into the regulation of progesterone receptors of various suggested markers of endometrial receptivity and the possibility of using mifepristone for endometrial contraception...
  2. ncbi request reprint Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception
    K Gemzell-Danielsson
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital Institute, S 171 76 Stockholm, Sweden
    Hum Reprod Update 10:341-8. 2004
    ....
  3. ncbi request reprint Misoprostol to treat missed abortion in the first trimester
    K Gemzell-Danielsson
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Int J Gynaecol Obstet 99:S182-5. 2007
    ..Bleeding may last for more than 14 days with additional days of light bleeding or spotting. The woman should be advised to contact a provider in case of heavy bleeding or signs of infection. A follow-up is recommended after 1 to 2 weeks...
  4. ncbi request reprint Effects of levonorgestrel on ovarian function when used for emergency contraception
    K Gemzell-Danielsson
    Department of Woman and Child Health, Karolinska University Hospital Karolinska Institutet, Stockholm, Sweden
    Minerva Ginecol 58:205-7. 2006
    ..Increased knowledge on mechanism of action could hopefully increase the acceptability, and thus availability of these methods, to offer women a chance to prevent an unwanted pregnancy and thus reduce the numbers of induced abortions...
  5. ncbi request reprint Studies on uterine contractility following mifepristone and various routes of misoprostol
    Kristina Gemzell-Danielsson
    Department of Obstetrics and Gynecology, Karolinska University Hospital, Karolinska Institute, SE 171 76 Stockholm, Sweden
    Contraception 74:31-5. 2006
    ..Recently, a new oral slow-release preparation of misoprostol has been studied. Future studies will show whether prostaglandin analogues with a prolonged effect on the myometrium may further improve the regimens for medical abortion...
  6. ncbi request reprint Pharmacokinetics of a novel oral slow-release form of misoprostol
    C Fiala
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, S 171 76 Stockholm, Sweden
    Hum Reprod 20:3414-8. 2005
    ..The pharmacokinetics of a novel slow-release (SR) misoprostol was studied and compared to conventional misoprostol...
  7. doi request reprint Effects of oral and vaginal administration of levonorgestrel emergency contraception on markers of endometrial receptivity
    C X Meng
    Division of Obstetrics and Gynaecology, Department of Women s and Children s Health, Karolinska University Hospital Karolinska Institutet, SE 17176 Stockholm, Sweden
    Hum Reprod 25:874-83. 2010
    ..We aimed to explore whether repeated oral and single vaginal administration of levonorgestrel affect the endometrium and thus potentially increase the EC efficacy, compared with the standard regimen...
  8. doi request reprint Replication of endometriosis-associated single-nucleotide polymorphisms from genome-wide association studies in a Caucasian population
    J Sundqvist
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Hospital, SE 17176 Stockholm, Sweden
    Hum Reprod 28:835-9. 2013
    ..Is it possible to replicate the previously identified genetic association of four single-nucleotide polymorphisms (SNPs), rs12700667, rs7798431, rs1250248 and rs7521902, with endometriosis in a Caucasian population?..
  9. doi request reprint Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days
    H Kopp Kallner
    Division of Obstetrics and Gynaecology, Department of Women s and Children s Health, Karolinska Institutet Karolinska University Hospital, 171 76 Stockholm, Sweden
    Hum Reprod 25:1153-7. 2010
    ....
  10. ncbi request reprint The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation
    C Fiala
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Clinical Epidemiology Unit, Karolinska Institute, 171 76 Stockholm, Sweden
    Hum Reprod 20:3072-7. 2005
    ....
  11. ncbi request reprint Prostaglandin E2 and F2alpha receptors in the human Fallopian tube before and after mifepristone treatment
    Kjell Wånggren
    Division of Woman and Child Health, Department of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden
    Mol Hum Reprod 12:577-85. 2006
    ....
  12. ncbi request reprint Effects of misoprostol on uterine contractility following different routes of administration
    A Aronsson
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institute Hospital, S 171 76 Stockholm, Sweden
    Hum Reprod 19:81-4. 2004
    ..The effect of misoprostol administered by different routes on pregnant uterine contractility was investigated...
  13. ncbi request reprint Effects of slow release misoprostol on uterine contractility in early pregnancy
    C Fiala
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Stockholm, Sweden
    Hum Reprod 20:2648-52. 2005
    ..The effect of a novel slow release form of misoprostol (SR misoprostol) on uterine activity during early pregnancy was investigated in a pilot study...
  14. doi request reprint Expression of adhesion, attachment and invasion markers in eutopic and ectopic endometrium: a link to the aetiology of endometriosis
    J Sundqvist
    Division of Obstetrics and Gynecology, Department of Women s and Children s Health, Karolinska Institutet Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Hum Reprod 27:2737-46. 2012
    ..Therefore, the aim of this study was to investigate the expression of proteins involved in adhesion, attachment and invasion in eutopic and ectopic endometrium...
  15. ncbi request reprint Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol
    A Aronsson
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska University Hospital, Karolinska Institutet, SE 171 76 Stockholm, Sweden
    Hum Reprod 22:1912-8. 2007
    ..No study has so far evaluated the pharmacokinetics beyond 6 hours. Furthermore a new slow-release misoprostol formulation was included in the study...
  16. ncbi request reprint Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration: a randomized comparison
    A Aronsson
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institute, S 171 76 Stockholm, Sweden
    Contraception 69:165-9. 2004
    ..It was shown that sublingual administration is more effective than oral administration of misoprostol for cervical priming and is associated with less blood loss but a higher frequency of side effects...
  17. ncbi request reprint Leukaemia inhibitory factor receptor and gp130 in the human Fallopian tube and endometrium before and after mifepristone treatment and in the human preimplantation embryo
    K Wånggren
    Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Karolinska University Hospital, S 171 76 Stockholm, Sweden
    Mol Hum Reprod 13:391-7. 2007
    ..Mifepristone did not affect the expression of LIFR and gp130 in the Fallopian tube, nor in the endometrium suggesting that progesterone might not be directly involved in the regulation of LIFR or gp130...
  18. ncbi request reprint Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen
    K Gemzell-Danielsson
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Hospital Institute, Stockholm, Sweden
    Hum Reprod 17:2588-93. 2002
    ..The safety and efficacy of the anti-progestogen Org 31710 in improving cycle control in healthy women using the desogestrel progestogen-only pill was investigated in this randomized, double-blind, placebo-controlled study...
  19. ncbi request reprint Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial
    I Sääv
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, S 171 76 Stockholm, Sweden
    Hum Reprod 22:2647-52. 2007
    ..However, insertion of an IUD through a narrow cervix may be technically difficult. Misoprostol has been shown to be effective for cervical priming in non-pregnant women prior to hysteroscopy...
  20. ncbi request reprint Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube
    A Christow
    Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Hospital, S 171 76 Stockholm, Sweden
    Mol Hum Reprod 8:333-40. 2002
    ..However an effect on the Fallopian tube could contribute to alter the peri-implantation milieu influencing fertilization and embryo development...
  21. doi request reprint Regulation of muscular contractions in the human Fallopian tube through prostaglandins and progestagens
    K Wånggren
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, Stockholm, Sweden
    Hum Reprod 23:2359-68. 2008
    ..The aim was to study the effect of PGs and progestagens, antiprogestin, hCG and oxytocin on muscular contractions in the human Fallopian tube, and the hormonal regulation of PG receptors...
  22. ncbi request reprint Misoprostol: first-line therapy for incomplete miscarriage in the developing world
    K Gemzell-Danielsson
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, Stockholm, Sweden
    BJOG 114:1337-9. 2007
  23. doi request reprint Ovarian cancer-associated polymorphisms in the BNC2 gene among women with endometriosis
    J Sundqvist
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, 171 76 Stockholm, Sweden
    Hum Reprod 26:2253-7. 2011
    ..Recent genome-wide association studies of ovarian cancer have identified several single nucleotide polymorphisms (SNPs) in the Basonuclin 2 (BNC2) gene. In this study, we investigated these polymorphism in women with endometriosis...
  24. doi request reprint Effect of bacterial vaginosis on the pharmacokinetics of misoprostol in early pregnancy
    A Sioutas
    Division of Obstetrics and Gynecology, Department of Women s and Children s Health, Karolinska Institutet Karolinska University Hospital, 17176 Stockholm, Sweden
    Hum Reprod 27:388-93. 2012
    ..Our objective was to evaluate whether bacterial vaginosis (BV) affected the pharmacokinetics of vaginally administered misoprostol during early pregnancy...
  25. ncbi request reprint Effect of mifepristone on the expression of cytokines in the human Fallopian tube
    H Z Li
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, S 171 76 Stockholm, Sweden
    Mol Hum Reprod 10:489-93. 2004
    ..Changes in cytokine expression in the Fallopian tube are likely to influence embryo development, which could contribute to the contraceptive effect of mifepristone...
  26. doi request reprint The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology
    M Engman
    Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital, 171 76 Stockholm, Sweden
    Hum Reprod 23:2072-9. 2008
    ..Progestins as well as estrogens have a role in breast cell proliferation and the development of breast cancer. Here, the effect of mifepristone on cell proliferation in human breast tissue in vivo was studied in premenopausal women...
  27. doi request reprint Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management
    Kristina Gemzell-Danielsson
    Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Reprod Health Matters 16:162-72. 2008
    ..Future studies should focus on improving pain management, the treatment of women with failed medical abortion after 24 hours, and the safety of medical abortion regimens in women with a previous caesarean section or uterine scar...
  28. ncbi request reprint Mechanisms of action of mifepristone when used for emergency contraception
    Kristina Gemzell-Danielsson
    Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Hospital Institute, S 171 76, Stockholm, Sweden
    Contraception 68:471-6. 2003
    ....
  29. ncbi request reprint Mid-trimester induced abortion: a review
    S Lalitkumar
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska University Hospital Karolinska Institute, Stockholm, Sweden
    Hum Reprod Update 13:37-52. 2007
    ..This review highlights the need for randomized studies to set guidelines for mid-trimester abortion methods in terms of safety and acceptability as well as for better analgesic regimens...
  30. doi request reprint Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial
    M Engman
    Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Karolinska University Hospital, 171 76 Stockholm, Sweden
    Hum Reprod 24:1870-9. 2009
    ..Uterine leiomyomas are widely prevalent and frequently cause menorrhagia. The major therapeutic option today is hysterectomy. Medical options are of highest interest...
  31. ncbi request reprint IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone
    H Falconer
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Reprod Biomed Online 18:582-8. 2009
    ..Further studies are needed to elucidate the role of AMH in predicting ovarian reserve in women with endometriosis...
  32. pmc Management of pain associated with the insertion of intrauterine contraceptives
    K Gemzell-Danielsson
    Department of Women s and Children s Health, Karolinska Institutet, Karolinska University Hospital, SE 17176 Stockholm, Sweden
    Hum Reprod Update 19:419-27. 2013
    ..This review critically evaluates the evidence for pain management strategies, formulates evidence-based recommendations and identifies data gaps and areas for further research...
  33. doi request reprint Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)--a multicentre prospective study
    K Gemzell-Danielsson
    Department of Obstetrics and Gynaecology, Karolinska University Hospital, Stockholm, Sweden
    Hum Reprod 25:354-9. 2010
    ..Thus, many women use the LNG-IUS consecutively. However, published data on the bleeding pattern regarding consecutive use of the LNG-IUS is scarce...
  34. ncbi request reprint Aquaporin 1 is expressed in the human endometrium during normal cycle and increases after mifepristone treatment
    Anna Hildenbrand
    Division of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
    Int J Mol Med 22:49-53. 2008
    ..The presence of AQP1 was also confirmed using RT-PCR. The changes in AQP1 expression could contribute to the reduced bleeding seen following mifepristone treatment and could be an effect of either antagonizing progesterone or cortisol...
  35. ncbi request reprint Emergency contraception with mifepristone and levonorgestrel: mechanism of action
    Lena Marions
    Department of Women and Child Health, Karolinska Hospital, Stockholm, Sweden
    Obstet Gynecol 100:65-71. 2002
    ..To study the effect of mifepristone and levonorgestrel on ovarian function and endometrial development in doses effective as emergency contraception...
  36. doi request reprint Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model
    Chun Xia Meng
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Fertil Steril 91:256-64. 2009
    ..To investigate the effect of levonorgestrel and mifepristone on the expression of endometrial receptivity markers in a three-dimensional endometrial construct...
  37. ncbi request reprint Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model
    P G L Lalitkumar
    Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital, S 171 76, Stockholm, Sweden
    Hum Reprod 22:3031-7. 2007
    ..This study investigates the effect of levonorgestrel and mifepristone on attachment of human embryos to an in vitro endometrial construct...
  38. ncbi request reprint Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function
    Lena Marions
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital Institute, 17176 Stockholm, Sweden
    Contraception 69:373-7. 2004
    ..This study indicates that, when used for EC, LNG or MIF administered prior to ovulation acts through an impaired ovulatory process and luteal function...
  39. doi request reprint An historical overview of second trimester abortion methods
    Marc Bygdeman
    Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Reprod Health Matters 16:196-204. 2008
    ....
  40. ncbi request reprint Expression of aquaporin-1 in endometrial blood vessels in menorrhagia
    Miriam Mints
    Department of Clinical Science, Division of Obstetrics and Gynecology, Karolinska University Hospital Huddinge, Karolinska Institutet, S 14186 Stockholm, Sweden
    Int J Mol Med 19:407-11. 2007
    ..006). Thus, the deregulation of aquaporin-1 in menorrhagia may be involved in abnormal endometrial vascular growth and permeability...
  41. ncbi request reprint Expression of aquaporin 2 in human endometrium
    Anna Hildenbrand
    Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
    Fertil Steril 86:1452-8. 2006
    ..To study the expression of aquaporin-2 (AQP2) in human endometrium...
  42. ncbi request reprint Perceptions of contraception, non-protection and induced abortion among a sample of urban Swedish teenage girls: focus group discussions
    Caroline Thorsén
    Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
    Eur J Contracept Reprod Health Care 11:302-9. 2006
    ..To explore the attitudes of teenage girls towards contraception and induced abortion in order to better understand underlying reasons for non-protection...
  43. ncbi request reprint Expression of heparin-binding epidermal growth factor-like growth factor and its receptors in the human fallopian tube and endometrium after treatment with mifepristone
    Xiao Xi Sun
    Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
    Fertil Steril 85:171-8. 2006
    ..To study the effect of mifepristone on heparin-binding epidermal growth factor (HB-EGF) and its receptors HER1 and HER4 in the fallopian tube and in the endometrium...
  44. ncbi request reprint The effect of mifepristone on the expression of insulin-like growth factor binding protein-1, prolactin and progesterone receptor mRNA and protein during the implantation phase in human endometrium
    Xiaoyan Qiu
    Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Hospital, S 171 76 Stockholm, Sweden
    Mol Hum Reprod 8:998-1004. 2002
    ..Our findings provide further insight into the regulation of IGFBP-1 and prolactin by PR in the human endometrium in vivo...
  45. ncbi request reprint Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial
    Helena von Hertzen
    Department of Reproductive Health and Research, WHO, Geneva, Switzerland
    Lancet 360:1803-10. 2002
    ..Because no studies had compared the efficacies of both compounds, or investigated a single dose of 1.5 mg levonorgestrel, we undertook this three-arm trial...
  46. ncbi request reprint Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristone
    Xiaoxi Sun
    Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Hospital Institute, S 171 76, Stockholm, Sweden
    Contraception 67:319-26. 2003
    ..These results further support the hypothesis that the contraceptive effect of mifepristone when given postovulatory is primarily due to alteration of the peri-implantation milieu influencing endometrial receptivity...
  47. ncbi request reprint Verifying the effectiveness of medical abortion; ultrasound versus hCG testing
    Christian Fiala
    Department of Obstetrics and Gynecology, General Public Hospital, Wiener Ring 3 5, 2100 Korneuburg, Austria
    Eur J Obstet Gynecol Reprod Biol 109:190-5. 2003
    ..The combination of mifepristone and misoprostol is an established method for termination of pregnancy. However, there is no general agreement about how best to evaluate the treatment outcome...
  48. ncbi request reprint WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy
    Helena von Hertzen
    UNDP UNFPA WHO World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
    BJOG 110:808-18. 2003
    ....
  49. ncbi request reprint Effects of mifepristone on expression of endothelial nitric oxide synthase in human endometrium during the implantation phase
    Xiaoxi Sun
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden
    Fertil Steril 80:1454-60. 2003
    ..To investigate the effects of the antiprogestin mifepristone on expression of endothelial (eNOS) nitric oxide synthase in human endometrium during the implantation phase...
  50. ncbi request reprint Action of mifepristone on the expression of insulin-like growth factor binding protein-1 mRNA and protein during the early luteal phase in the human oviduct
    Xiaoyan Qiu
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden
    Fertil Steril 80:776-82. 2003
    ..To investigate the effects of the antiprogestin mifepristone on the expression of insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and protein during the early luteal phase in the human oviduct...
  51. ncbi request reprint WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion
    Helena Honkanen
    Helsinki University Central Hospital, Finland
    BJOG 111:715-25. 2004
    ..To compare the side effect profiles of regimens of oral and vaginal administration of misoprostol after a single oral dose of 200 mg of mifepristone and to investigate patients' perceptions of medical abortion...
  52. ncbi request reprint Acceptability of home-use of misoprostol in medical abortion
    Christian Fiala
    Division for Obstetrics and Gynaecology, Department of Woman and Child Health, Karolinska Hospital Institute, S 171 76 Stockholm, Sweden
    Contraception 70:387-92. 2004
    ..Home-use of misoprostol would reduce the number of visits and improve access to medical abortion. We evaluated acceptance of home-use of misoprostol among women and their partners...
  53. ncbi request reprint Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone
    Caroline Arvidsson
    Department of Obstetrics and Gynecology, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Eur J Obstet Gynecol Reprod Biol 123:87-91. 2005
    ..To compare the experience of pain, need of analgesic interventions, preference and acceptability in medical abortion up to 49 days of amenorrhea with mifepristone and orally versus vaginally administered misoprostol...
  54. ncbi request reprint The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy
    Annette Aronsson
    Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Institute, S 171 76 Stockholm, Sweden
    Contraception 72:33-9. 2005
    ..The objective of the present study was to investigate the effect of vaginally and orally administered misoprostol on the local cervical inflammatory response...
  55. ncbi request reprint Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH)
    Qiu ju Chen
    Department of Reproductive Medicine, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University, Shanghai, P R China
    Acta Obstet Gynecol Scand 86:849-54. 2007
    ....
  56. ncbi request reprint Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone
    Hans Joachim Ahrendt
    Halberstädter Strasse 122, D 39112 Magdeburg, Germany
    Contraception 74:451-7. 2006
    ..This randomized multicenter, open-label, trial compared efficacy, acceptability, tolerability and compliance of NuvaRing with a combined oral contraceptive (COC), containing 30 microg of ethinyl estradiol (EE) and 3 mg of drospirenone...
  57. ncbi request reprint Effects of ovarian stimulation on endometrial integrin beta3 and leukemia inhibitory factor expression in the peri-implantation phase
    Qiu ju Chen
    Department of Reproductive Medicine, International Peace Maternity and Child Health Hospital, Shanghai, Peoples Republic of China
    Fertil Steril 89:1357-63. 2008
    ..To investigate the effects of ovarian stimulation on endometrial receptivity in the peri-implantation phase...
  58. doi request reprint Tolerability and clinical safety of Implanon
    Paul D Blumenthal
    Family Planning Services and Research, Department of Obstetrics and Gynecology, Stanford University, Stanford, CA, USA
    Eur J Contracept Reprod Health Care 13:29-36. 2008
    ..To evaluate the tolerability and clinical safety of the subdermal, long-acting hormonal contraceptive Implanon...
  59. ncbi request reprint Knowledge, attitudes and prescribing pattern of emergency contraceptives by health care workers in Kampala, Uganda
    Josaphat K Byamugisha
    Department of Obstetrics and Gynecology, Faculty of Medicine, Makerere University, Kampala, Uganda
    Acta Obstet Gynecol Scand 86:1111-6. 2007
    ..However, in some settings, HCWs have been blamed for unfavourable attitudes and lack of accurate information. Objective. To assess the knowledge, attitudes and prescribing pattern of EC by HCWs in Kampala district, Uganda...